5.57
-0.225(-3.88%)
Currency In USD
| Previous Close | 5.8 |
| Open | 5.78 |
| Day High | 5.88 |
| Day Low | 5.52 |
| 52-Week High | 25.7 |
| 52-Week Low | 3 |
| Volume | 74,098 |
| Average Volume | 285,123 |
| Market Cap | 37.52M |
| PE | -0.51 |
| EPS | -10.84 |
| Moving Average 50 Days | 6.09 |
| Moving Average 200 Days | 5.25 |
| Change | -0.23 |
If you invested $1000 in Generation Bio Co. (GBIO) since IPO date, it would be worth $22.56 as of October 30, 2025 at a share price of $5.57. Whereas If you bought $1000 worth of Generation Bio Co. (GBIO) shares 3 years ago, it would be worth $108.79 as of October 30, 2025 at a share price of $5.57.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Generation Bio Announces CEO Transition
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President CAMBRIDGE, MASS., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Generation
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
GlobeNewswire Inc.
Aug 12, 2025 8:05 PM GMT
• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T c
Generation Bio Announces 1-for-10 Reverse Stock Split
GlobeNewswire Inc.
Jul 18, 2025 12:35 PM GMT
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that it will implement a 1-fo